Categories AlphaGraphs, Earnings, Health Care
Infographic: Key numbers from Johnson & Johnson (JNJ) Q2 2020 earnings announcement
Johnson & Johnson (NYSE: JNJ) reported second quarter 2020 earnings results today.
Reported sales decreased 10.8% to $18.3 billion. GAAP earnings fell 35% to $3.6 billion, or $1.36 per share. Adjusted EPS dropped 35% to $1.67.
The company raised its guidance for the full year of 2020. Reported sales are estimated to come in the range of $79.9-81.4 billion and adjusted EPS is expected to be $7.75-7.95.
Check this space for the transcript of Johnson & Johnson Q2 2020 earnings conference call
Past Performance
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
